The advanced lung cancer inflammation index (ALI) differs from previously established markers by incorporating not only the NLR and albumin (Alb), but also body mass index (BMI) (9), thereby providing a more comprehensive representation of both inflammation and nutritional status in patients with advanced lung cancer (10). This evidence concerns the gene ALB and lung carcinoma.